| http://dbpedia.org/ontology/abstract
|
Viralytics Ltd is an Australian biotechnol … Viralytics Ltd is an Australian biotechnology company working in the field of oncolytic viruses, that is, viruses that preferentially infect and kill cancer cells. The company's oncolytic virus product, called Cavatak, is currently in clinical trials in metastatic melanoma and other cancers. The drug was granted Orphan Drug status in advanced melanoma in December 2005.tus in advanced melanoma in December 2005.
|
| http://dbpedia.org/ontology/foundingYear
|
2006
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/Paul_A._Hopper +
|
| http://dbpedia.org/ontology/product
|
http://dbpedia.org/resource/Cavatak +
|
| http://dbpedia.org/ontology/wikiPageID
|
48722637
|
| http://dbpedia.org/ontology/wikiPageLength
|
20981
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1064310841
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Co-receptor +
, http://dbpedia.org/resource/RNA +
, http://dbpedia.org/resource/Non-small-cell_lung_carcinoma +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Open-label_trial +
, http://dbpedia.org/resource/Art_deco +
, http://dbpedia.org/resource/GM-CSF +
, http://dbpedia.org/resource/Merck_&_Co. +
, http://dbpedia.org/resource/Virotherapy +
, http://dbpedia.org/resource/Capsid +
, http://dbpedia.org/resource/RECIST +
, http://dbpedia.org/resource/Breast_Cancer_Research_and_Treatment +
, http://dbpedia.org/resource/Subsidiary +
, http://dbpedia.org/resource/International_Journal_of_Oncology +
, http://dbpedia.org/resource/OTC_Markets_Group +
, http://dbpedia.org/resource/Keytruda +
, http://dbpedia.org/resource/Category:Merck_&_Co. +
, http://dbpedia.org/resource/Clinical_Cancer_Research +
, http://dbpedia.org/resource/Bristol-Myers_Squibb +
, http://dbpedia.org/resource/Trade_name +
, http://dbpedia.org/resource/Oncolytic_virus +
, http://dbpedia.org/resource/Newcastle%2C_New_South_Wales +
, http://dbpedia.org/resource/Orphan_Drug +
, http://dbpedia.org/resource/Cavatak +
, http://dbpedia.org/resource/Hunter_Street%2C_Sydney +
, http://dbpedia.org/resource/Paul_A._Hopper +
, http://dbpedia.org/resource/Genome +
, http://dbpedia.org/resource/Bladder_cancer +
, http://dbpedia.org/resource/Category:Cancer_research +
, http://dbpedia.org/resource/University_of_Newcastle_%28Australia%29 +
, http://dbpedia.org/resource/Category:2018_mergers_and_acquisitions +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_Australia +
, http://dbpedia.org/resource/ICAM-1 +
, http://dbpedia.org/resource/Coxsackievirus +
, http://dbpedia.org/resource/ClinicalTrials.gov +
, http://dbpedia.org/resource/The_Prostate +
, http://dbpedia.org/resource/Human_enterovirus_C +
, http://dbpedia.org/resource/Merck_&_Co +
, http://dbpedia.org/resource/CT_scan +
, http://dbpedia.org/resource/Wild-type +
, http://dbpedia.org/resource/British_Journal_of_Haematology +
, http://dbpedia.org/resource/Mitomycin_C +
, http://dbpedia.org/resource/CSL_Limited +
, http://dbpedia.org/resource/Prostate_cancer +
, http://dbpedia.org/resource/Multiple_myeloma +
, http://dbpedia.org/resource/Investigational_New_Drug +
, http://dbpedia.org/resource/American_depositary_receipt +
, http://dbpedia.org/resource/Viral_entry +
, http://dbpedia.org/resource/Oncolysis +
, http://dbpedia.org/resource/Immune-Related_Response_Criteria +
, http://dbpedia.org/resource/Decay-accelerating_factor +
, http://dbpedia.org/resource/Picornaviridae +
, http://dbpedia.org/resource/American_Society_of_Clinical_Oncology +
, http://dbpedia.org/resource/Australian_Securities_Exchange +
, http://dbpedia.org/resource/Yervoy +
|
| http://dbpedia.org/property/foundation
|
2006
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/keyPeople
|
http://dbpedia.org/resource/Paul_A._Hopper +
, Malcolm McColl
, (Non-Executive chairman)
, Darren Shafren
|
| http://dbpedia.org/property/location
|
Sydney
|
| http://dbpedia.org/property/name
|
Viralytics Ltd
|
| http://dbpedia.org/property/products
|
Cavatak, an oncylytic virus
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:URL +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Third-party +
, http://dbpedia.org/resource/Template:Schering-Plough +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Use_dmy_dates +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:2018_mergers_and_acquisitions +
, http://dbpedia.org/resource/Category:Merck_&_Co. +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_Australia +
, http://dbpedia.org/resource/Category:Cancer_research +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Company +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Viralytics?oldid=1064310841&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Viralytics +
|
| http://xmlns.com/foaf/0.1/name
|
Viralytics Ltd
|
| owl:sameAs |
http://dbpedia.org/resource/Viralytics +
, http://yago-knowledge.org/resource/Viralytics +
, http://rdf.freebase.com/ns/m.0pk_dc3 +
, https://global.dbpedia.org/id/4gPUd +
, http://www.wikidata.org/entity/Q5054874 +
|
| rdf:type |
http://dbpedia.org/class/yago/WikicatBrands +
, http://dbpedia.org/ontology/Agent +
, http://dbpedia.org/class/yago/Name106333653 +
, http://dbpedia.org/class/yago/LanguageUnit106284225 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.wikidata.org/entity/Q43229 +
, http://www.wikidata.org/entity/Q4830453 +
, http://dbpedia.org/class/yago/Part113809207 +
, http://dbpedia.org/ontology/Company +
, http://schema.org/Organization +
, http://dbpedia.org/class/yago/Relation100031921 +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/class/yago/TradeName106845599 +
|
| rdfs:comment |
Viralytics Ltd is an Australian biotechnol … Viralytics Ltd is an Australian biotechnology company working in the field of oncolytic viruses, that is, viruses that preferentially infect and kill cancer cells. The company's oncolytic virus product, called Cavatak, is currently in clinical trials in metastatic melanoma and other cancers. The drug was granted Orphan Drug status in advanced melanoma in December 2005.tus in advanced melanoma in December 2005.
|
| rdfs:label |
Viralytics
|
